AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2017
Jul 28, 2017
5262_dirs_2017-07-28_8d415a67-fc68-4bab-974c-8067b3e00c3f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4865M
GlaxoSmithKline PLC
28 July 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mrs V A Whyte | |||
| b) | Position/status | SVP & Company Secretary | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | A conditional award of Ordinary Shares under the Company's 2017 Performance Share Plan. Vesting of the award is subject to meeting performance criteria over a three year period. | |||
| c) | Price(s) and volume(s) |
Price(s) | Volume(s) | ||
| £15.31 | 12,105 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-07-27 | |||
| f) | Place of the transaction | n/a |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEVLFLDDFBBBB
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Foreign Filer Report
2026
May 22
Director's Dealing
2026
May 20
Foreign Filer Report
2026
May 20
Foreign Filer Report
2026
May 20
Director's Dealing
2026
May 19
Foreign Filer Report
2026
May 19
Transaction in Own Shares
2026
May 18
Foreign Filer Report
2026
May 18
Foreign Filer Report
2026
May 18